|
Post by compound26 on Dec 14, 2015 13:40:23 GMT -5
Things look rather bad and everyone is depressed so I couldn't resist but to buy back in with a small nibble. This is a good drug. Don't know what the risk reward is but at these prices it is starting to feel like a good gamble (and yes it is a gamble that Sanofi is not dumping them and that they have at least 6 months of cash). JPG, wellcome back. Agree, the stock is way oversold here at this level by tax-selling aggravated by shorting + FUD spread by shots. If Mannk is able to pull in some funds (say, $100-200 million funds, whether from Sanof, a TS partner, debt or equity financing, or a combination of them, or anywhere else) within the next 6-12 months, which I think is more than likely, I think we should at least triple from here (now market cap is $600 million, a triple from here is still less than $2 billion in market cap).
|
|
|
Post by dreamboatcruise on Dec 14, 2015 13:51:10 GMT -5
It's anecdotal but it's not the first time we have heard of patients going off other meds due to using Afrezza. I don't think it will be the last time we hear it either. I wonder if he means oral anti-diabetes or some other pills. Seems to imply an overall cost savings going on Afrezza, but I wouldn't think that would be the case simply with oral anti-diabetes medication. Metformin is usually one of them and it is very cheap.
|
|
|
Post by silentknight on Dec 14, 2015 15:55:07 GMT -5
Well, I broke my own rule today and bought another 1k shares at 1.40. I'm down 100K so I figured I'd throw another 1500 or so out there too. The shares are pretty worthless at current levels so that's chump change. If I'm going to lose it all, I really might as well lose it all.
|
|